HC Wainwright & Co. Downgrades Evommune to Neutral

Benzinga Newsdesk www.benzinga.com Negative 88.6%

Neg 88.6% Neu 0% Pos 0%

HC Wainwright & Co. analyst Mitchell S. Kapoor downgrades Evommune (NYSE:EVMN) from Buy to Neutral.

Comments

No comments yet. Be the first!